SG3 Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,000
Closed -$94.2K 33
2022
Q4
$94.2K Sell
15,000
-24,200
-62% -$169K 0.01% 176
2022
Q3
$270K Sell
39,200
-196,000
-83% -$1.36M 0.04% 179
2022
Q2
$1.97M Sell
235,200
-255,300
-52% -$3.57M 0.23% 82
2022
Q1
$11.2M Buy
490,500
+312,600
+176% +$7.64M 0.31% 71
2021
Q4
$4.91M Buy
+177,900
New +$4.76M 0.1% 174
2021
Q3
Sell
-100,000
Closed -$2.93M 1005
2021
Q2
$2.93M Buy
+100,000
New +$3.03M 0.1% 220

Other funds holding BHC

SG3 Management's BHC Position: Q3 2022 in Review

SG3 Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 770,500 shares — an estimated $5.35M sold.

SG3 Management first reported a position in BHC in Q1 2021 and held it in 6 quarters. The position peaked at $37.9M in Q1 2022. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • SG3 Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • SG3 Management sold 770,500 Bausch Health shares in Q3 2022, an estimated $5.35M.
  • SG3 Management first reported a position in Bausch Health in Q1 2021 and held it in 6 quarters.
  • SG3 Management's Bausch Health position peaked at $37.9M in Q1 2022.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.